Literature DB >> 17890417

Stabilization of juvenile metachromatic leukodystrophy after bone marrow transplantation: a 13-year follow-up.

Maria Görg1, Wanja Wilck, Barbara Granitzny, Anne Suerken, Zoltan Lukacs, Xiaoqi Ding, Michael Schulte-Markwort, Alfried Kohlschütter.   

Abstract

A 29-year-old female patient with juvenile metachromatic leukodystrophy diagnosed at age 14 years received a bone marrow transplant at age 16 years. A report was published 6 years after bone marrow transplantation concluding that the disease had slowly progressed in the 2 years following bone marrow transplantation. We now report on a further 7-year follow-up, typified by a steady state of spastic paraplegia and mild dementia. Neurophysiological, neuroradiological, and psychological status also remained stable. In the patient's leukocytes, the activity of arylsulfatase A, the enzyme deficient in untreated metachromatic leukodystrophy, was within the normal range whereas urinary sulfatides remained elevated. Data on the natural course of juvenile metachromatic leukodystrophy are rare, so in the present case it is difficult to establish whether the rather favorable course can be attributed with certainty to bone marrow transplantation. The long-term stabilization in this patient, however, suggested that bone marrow transplantation may halt the progression of juvenile metachromatic leukodystrophy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890417     DOI: 10.1177/0883073807306256

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  10 in total

1.  Unrelated umbilical cord blood transplant for juvenile metachromatic leukodystrophy: a 5-year follow-up in three affected siblings.

Authors:  Casey Cable; Richard S Finkel; Tanya J Lehky; Nadia M Biassou; Edythe A Wiggs; Nancy Bunin; Tyler Mark Pierson
Journal:  Mol Genet Metab       Date:  2010-10-28       Impact factor: 4.797

Review 2.  Metachromatic leukodystrophy: a case of triplets with the late infantile variant and a systematic review of the literature.

Authors:  Asif Mahmood; Jay Berry; David A Wenger; Maria Escolar; Magdi Sobeih; Gerald Raymond; Florian S Eichler
Journal:  J Child Neurol       Date:  2009-12-28       Impact factor: 1.987

3.  Delivering drugs to the central nervous system: an overview.

Authors:  Patricia I Dickson
Journal:  Drug Deliv Transl Res       Date:  2012-06       Impact factor: 4.617

4.  Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophy.

Authors:  M Solders; D A Martin; C Andersson; M Remberger; T Andersson; O Ringdén; G Solders
Journal:  Bone Marrow Transplant       Date:  2014-05-05       Impact factor: 5.483

5.  Haematopoietic stem cell transplantation does not retard disease progression in the psycho-cognitive variant of late-onset metachromatic leukodystrophy.

Authors:  Nicholas J Smith; Robert E Marcus; Barbara J Sahakian; Narinder Kapur; Timothy M Cox
Journal:  J Inherit Metab Dis       Date:  2010-11-16       Impact factor: 4.982

6.  Extremely low arylsulfatase A enzyme activity does not necessarily cause symptoms: A long-term follow-up and review of the literature.

Authors:  Lucia Laugwitz; Vidiyaah Santhanakumaran; Mareike Spieker; Judith Boehringer; Benjamin Bender; Volkmar Gieselmann; Stefanie Beck-Woedl; Gernot Bruchelt; Klaus Harzer; Ingeborg Kraegeloh-Mann; Samuel Groeschel
Journal:  JIMD Rep       Date:  2022-05-04

7.  Long-term disease course of two patients with multiple sulfatase deficiency differs from metachromatic leukodystrophy in a broad cohort.

Authors:  Stefanie Beck-Wödl; Christiane Kehrer; Klaus Harzer; Tobias B Haack; Friederike Bürger; Dorothea Haas; Angelika Rieß; Samuel Groeschel; Ingeborg Krägeloh-Mann; Judith Böhringer
Journal:  JIMD Rep       Date:  2020-12-08

8.  Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report.

Authors:  Alexander A Boucher; Weston Miller; Ryan Shanley; Richard Ziegler; Troy Lund; Gerald Raymond; Paul J Orchard
Journal:  Orphanet J Rare Dis       Date:  2015-08-07       Impact factor: 4.123

9.  Language and cognition in children with metachromatic leukodystrophy: onset and natural course in a nationwide cohort.

Authors:  Christiane Kehrer; Samuel Groeschel; Birgit Kustermann-Kuhn; Friederike Bürger; Wolfgang Köhler; Alfried Kohlschütter; Annette Bley; Robert Steinfeld; Volkmar Gieselmann; Ingeborg Krägeloh-Mann
Journal:  Orphanet J Rare Dis       Date:  2014-02-05       Impact factor: 4.123

Review 10.  Novel therapies for mucopolysaccharidosis type III.

Authors:  Berna Seker Yilmaz; James Davison; Simon A Jones; Julien Baruteau
Journal:  J Inherit Metab Dis       Date:  2020-09-28       Impact factor: 4.982

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.